Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed
Search for other papers by Diego Ferone in
Google Scholar
PubMed
Search for other papers by Jens Sandahl Christiansen in
Google Scholar
PubMed
Search for other papers by David Gilfoyle in
Google Scholar
PubMed
Search for other papers by Eva Dam Christoffersen in
Google Scholar
PubMed
Search for other papers by Eva Mortensen in
Google Scholar
PubMed
Search for other papers by Jonathan A Leff in
Google Scholar
PubMed
Search for other papers by Michael Beckert in
Google Scholar
PubMed
reactions (defined as erythema, swelling and pain) at 8, 12 and 24 h after dose on Days 8 and 15 as well as by patient diary. Blood samples for PK and PD assessments in the TransCon GH cohorts were collected at Day 0 and pre-dose on Days 1, 8, 15 and 22
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Johan Botling in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Barbro Eriksson in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Anders Sundin in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
grading of panNENs ( 3 ), high-grade neoplasms were separated into two categories: well-differentiated (WD) pancreatic neuroendocrine tumor grade 3 (panNET-G3) and poorly differentiated (PD) NEC ( 4 ). PanNET-G3 frequently harbors mutations in MEN1 and
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, University Regional Hospital of Patras, Rio, Greece
Mount Auburn Hospital, Harvard Medical School Teaching Hospital, Cambridge, Massachusetts, USA
Search for other papers by M I Stamou in
Google Scholar
PubMed
Search for other papers by P Varnavas in
Google Scholar
PubMed
Search for other papers by L Plummer in
Google Scholar
PubMed
Search for other papers by V Koika in
Google Scholar
PubMed
Search for other papers by N A Georgopoulos in
Google Scholar
PubMed
effect PP Pathogenicity MAF in ExAC browse non-Finnish Europeans No of probands Dx CHD7 c.8962 8963insG p.D2988GfsX2 Frameshift NA Deleterious Not seen 1 nIHH CHD7 c.5051-4C>T Splice site NA Deleterious
Search for other papers by Rossella Cannarella in
Google Scholar
PubMed
Search for other papers by Teresa Mattina in
Google Scholar
PubMed
Search for other papers by Rosita A Condorelli in
Google Scholar
PubMed
Search for other papers by Laura M Mongioì in
Google Scholar
PubMed
Search for other papers by Giuseppe Pandini in
Google Scholar
PubMed
Search for other papers by Sandro La Vignera in
Google Scholar
PubMed
Search for other papers by Aldo E Calogero in
Google Scholar
PubMed
Introduction Insulin-like growth factor 1 receptor ( IGF1R ) gene, made up of 315,991 base pairs, maps on the 15q26.3 chromosome. It encodes for a protein with a tyrosine kinase domain, which binds the IGF1 and is responsible for its
Search for other papers by Martin Zweifel in
Google Scholar
PubMed
Search for other papers by Beat Thürlimann in
Google Scholar
PubMed
Search for other papers by Salome Riniker in
Google Scholar
PubMed
Search for other papers by Patrik Weder in
Google Scholar
PubMed
Search for other papers by Roger von Moos in
Google Scholar
PubMed
Search for other papers by Olivia Pagani in
Google Scholar
PubMed
Search for other papers by Martin Bigler in
Google Scholar
PubMed
Search for other papers by Karin M Rothgiesser in
Google Scholar
PubMed
Search for other papers by Christiane Pilop in
Google Scholar
PubMed
Search for other papers by Hanne Hawle in
Google Scholar
PubMed
Search for other papers by Peter Brauchli in
Google Scholar
PubMed
Search for other papers by Coya Tapia in
Google Scholar
PubMed
Search for other papers by Wolfgang Schoenfeld in
Google Scholar
PubMed
Search for other papers by Cristiana Sessa in
Google Scholar
PubMed
Search for other papers by for the Swiss Group for Clinical Cancer Research (SAKK) in
Google Scholar
PubMed
included as an additional secondary endpoint later on. Pharmacokinetics (PK) and pharmacodynamics (PD) Plasma and serum 4-OHT, 4-OHA (for PK) and oestradiol (for PD) concentrations were measured at baseline, after single dose administration at 1, 2
Search for other papers by Paweł Komarnicki in
Google Scholar
PubMed
Search for other papers by Paweł Gut in
Google Scholar
PubMed
Search for other papers by Jan Musiałkiewicz in
Google Scholar
PubMed
Search for other papers by Maja Cieślewicz in
Google Scholar
PubMed
Search for other papers by Adam Maciejewski in
Google Scholar
PubMed
Search for other papers by Prachi Patel in
Google Scholar
PubMed
Search for other papers by George Mastorakos in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
%) G2 22 (54%) Treatment response sd 20 (49%) pd 21 (51%) Ki 67 1% 2 (5%) 2% 17 (41%) 4% 2 (5%) 5% 8 (20%) 10% 12 (29%) * Mean ( s.d. ). LTB was
Search for other papers by Wei Li in
Google Scholar
PubMed
Search for other papers by Qing Huang in
Google Scholar
PubMed
Search for other papers by Danyang Sun in
Google Scholar
PubMed
Search for other papers by Guizhi Zhang in
Google Scholar
PubMed
Search for other papers by Jian Tan in
Google Scholar
PubMed
particles and technical assistance. References 1 Chen W Zheng R Baade PD Zhang S Zeng H Bray F Jemal A Yu XQ He J . Cancer statistics in China, 2015 . CA: A Cancer Journal for Clinicians 2016 66 115 – 132
Department of Endocrinology, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Unni Syversen in
Google Scholar
PubMed
Medical Clinic, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Mats Peder Mosti in
Google Scholar
PubMed
Search for other papers by Ida Maria Mynarek in
Google Scholar
PubMed
Search for other papers by Trude Seselie Jahr Vedal in
Google Scholar
PubMed
Department of Gastroenterology, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Kristin Aasarød in
Google Scholar
PubMed
Search for other papers by Trude Basso in
Google Scholar
PubMed
Search for other papers by Janne E Reseland in
Google Scholar
PubMed
Search for other papers by Per Medbøe Thorsby in
Google Scholar
PubMed
K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Trondheim, Norway
Search for other papers by Bjorn O Asvold in
Google Scholar
PubMed
Search for other papers by Erik Fink Eriksen in
Google Scholar
PubMed
Medical Clinic, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Astrid Kamilla Stunes in
Google Scholar
PubMed
density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis . Osteoporosis International 2007 18 427 – 444 . ( https://doi.org/10.1007/s00198-006-0253-4 ) 5 Chavassieux P Seeman E Delmas PD . Insights into
Search for other papers by B C M Hermans in
Google Scholar
PubMed
Search for other papers by J L Derks in
Google Scholar
PubMed
Search for other papers by H J M Groen in
Google Scholar
PubMed
Search for other papers by J A Stigt in
Google Scholar
PubMed
Search for other papers by R J van Suylen in
Google Scholar
PubMed
Search for other papers by L M Hillen in
Google Scholar
PubMed
Search for other papers by E C van den Broek in
Google Scholar
PubMed
Search for other papers by E J M Speel in
Google Scholar
PubMed
Search for other papers by A-M C Dingemans in
Google Scholar
PubMed
Thorax, adrenal gland, liver Eto-carbo 12 D Male 49 N/a 1 0 Lobectomy + metastasectomy + WBRT 12 At least brain Resection 18 E Male 55 >40 1a 0 Lobectomy + metastasectomy + chemotherapy (cis-pem, PD) 4
Search for other papers by Hélène Singeisen in
Google Scholar
PubMed
Search for other papers by Mariko Melanie Renzulli in
Google Scholar
PubMed
Search for other papers by Vojtech Pavlicek in
Google Scholar
PubMed
Search for other papers by Pascal Probst in
Google Scholar
PubMed
Search for other papers by Fabian Hauswirth in
Google Scholar
PubMed
Search for other papers by Markus K Muller in
Google Scholar
PubMed
Search for other papers by Magdalene Adamczyk in
Google Scholar
PubMed
Search for other papers by Achim Weber in
Google Scholar
PubMed
Search for other papers by Reto Martin Kaderli in
Google Scholar
PubMed
Search for other papers by Pietro Renzulli in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia (MEN) is a rare group of autosomal dominant disorders with a wide spectrum of endocrine and non-endocrine manifestations ( Table 1 ). Five different types of MEN have been described so far: MEN1, MEN2